A doctor in a white coat and wearing a stethoscope is using a virtual digital...

News • Cardiology congress presence

New AI-powered solutions for cardiac ultrasound at ESC 2025

Esaote Group, an Italian company specializing in medical imaging – ultrasound, dedicated magnetic resonance, and medical IT – will be present at the European Society of Cardiology (ESC) Congress 2025, taking place from 29th August to 1st September at Ifema Madrid (Booth A280, Exhibition Hall West).

At the heart of Esaote’s showcase is a comprehensive portfolio of cardiovascular imaging technologies designed to enhance diagnostic precision, streamline workflows, and support clinical decision-making across the entire care continuum.

Among the highlights will be the launch of the MyLab™C30* cardio, a portable ultrasound system engineered specifically for cardiology. With the largest-in-class touchscreen, an intuitive touch interface, and AI-powered tools, the system aims to significantly reduce examination time while ensuring diagnostic confidence—even in the most complex cases, by providing reliable qualitative and quantitative assessments. Its extended battery life and robust performance make it ideal for both routine and emergency settings, the company reports.

Also being introduced is HeartScan Assistant, a new AI-powered feature to support guidance for Cardiac Ultrasound. It is designed to empower healthcare professionals with the acquisition of transthoracic cardiac ultrasound images by providing real-time AI feedback on view classification and image quality. This accelerates daily practice for all cardiologists, particularly benefiting emergency care settings and less experienced professionals.

Shaping the future of medical imaging

For Esaote, a leading Italian innovator in medical imaging - ultrasound, dedicated magnetic resonance and medical IT - the mission is to develop new technologies that can help advance diagnosis and improve patient care. Esaote has always leveraged continuous innovation as the key driver of its business strategy. This approach is also embodied in its three business areas.

An insightful presentation on Hyperdoppler techniques and their clinical applications will be held on Saturday, 30th August, from 12:00 to 13:30 at the Esaote booth to assess how force distribution analysis can identify dilated or dysfunctional hearts and monitor the impact of resynchronization therapies in heart failure patients.

On the healthcare IT front, Ebit, the Healthcare IT company of Esaote, will showcase the latest edition of its Suitestensa CVIS PACS platform. Designed for both ambulatory and interventional cardiology, the platform integrates AI-powered tools such as fAInd for clinical decision support and ZEfiRO for intelligent workflow orchestration. It also offers seamless integration with advanced tools like CAAS Qardia, an echocardiography suite developed by Pie Medical Imaging (part of the Esaote Group). The upcoming version v2.2 – showcased at ESC - introduces Qardia View Classifier, an AI-powered assistant designed to pre-select optimal images for standardized measurements, minimizing manual selection and reducing time spent navigating through image sets. Furthermore, critical echo measurements, including myocardial strain and cardiac dimensions are now automated. CAAS Qardia enables both standalone and zero-footprint access via web browser.

With its presence at ESC 2025, Esaote Group says it reaffirms its commitment to advancing cardiovascular diagnostics through innovation, clinical collaboration, and ongoing R&D investment.

*FDA pending. Not available for sale in the United States

Source: Esaote

29.08.2025